Researchers speculate that this protection offered by a higher percentage of leg fat could help identify those at low risk of high blood pressure, or alternatively serve as a target for prevention efforts, although more studies are needed.
Reducing hypertension medications if and when COVID-19 patients become hypotensive could prevent acute kidney injury and death, according to a new study.
COVID-19 patients previously taking the blood pressure-lowering drugs angiotensin-converting enzyme inhibitors (ACE-i) and angiotensin receptor blockers (ARBs) are more likely to die than those who were not taking the medications.
It is important to note that patients taking ACE-i and/or ARBs may have more advanced cardiovascular disease or other chronic health conditions that further increase the risk for serious complications of COVID-19.
Source: American Heart Association
Source: Université de Genève
Their results suggest that adherence to the MD could reduce the high risk of RA among ever‐smoking women.
Release date: 9 September 2020
NIH research finds higher risk and worse outcomes for those with addiction.
Release date: 14 September 2020
The widely used and well-tolerated drug commonly used to treat Parkinson’s disease may help significantly reduce the need for more costly, more invasive treatments, report investigators in The American Journal of Medicine.
Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with levodopa, a safe and readily available drug commonly used to treat Parkinson’s disease, stabilized and improved their vision. It reduced the number of treatments necessary to maintain vision, and as such, will potentially reduce the burden of treating the disease, financially and otherwise.
Release date: 10 September 2020
People who took acetaminophen rated activities like “bungee jumping off a tall bridge” and “speaking your mind about an unpopular issue in a meeting at work” as less risky than people who took a placebo, researchers found.
Use of the drug also led people to take more risks in an experiment where they could earn rewards by inflating a virtual balloon on a computer: Sometimes they went too far and the balloon popped.
The study was published online in the journal Social Cognitive and Affective Neuroscience.
Release date: 8 September 2020
Source: Ohio State University